MITCHELL S FELDER
Medical Practice in Hermitage, PA

5801009, Sep 1, 1998

Jul 21, 1997

8/897815

Mitchell S. Felder - Hermitage PA

Infectech, Inc. - Sharon PA

C12M 300

435 29

An apparatus for determining sensitivity of at least one paraffinophilic microorganism from a specimen obtained from a patient to different antimicrobial agents and predetermined quantities thereof. The apparatus includes a receptacle adapted to contain an aqueous solution, an amount of antimicrobial agent to be tested and the specimen. The aqueous solution is adjusted to mimic the in vivo clinical conditions of the patient. The apparatus further includes a paraffin coated slide adapted to being placed in the receptacle.

5641645, Jun 24, 1997

Nov 9, 1995

8/556033

Mitchell S. Felder - Hermitage PA
Robert- A. Ollar - Milford PA

Infectech, Inc. - Sharon PA

C12Q 102, C12Q 104, C12Q 118, G01N 3348

435 32

A method for determining the sensitivity of at least one nonparaffinophilic microorganism from a specimen obtained from a patient to different antimicrobial agent, and predetermined quantities thereof. The method includes providing at least one receptacle containing an aqueous solution and adjusting the solution to mimic the in vivo clinical conditions of said patient. The method further includes inoculating the solution with the specimen and placing into the receptacle (i) a slide coated with a carbon source and (ii) a predetermined quantity of an antimicrobial agent to be tested. By observing the nonparaffinophilic microorganism growth or lack thereof on the slide, it can be determined whether the predetermined quantity of the antimicrobial agent is effective in inhibiting growth of the nonparaffinophilic microorganism on the slide. An associated apparatus is also disclosed.

5962306, Oct 5, 1999

Jan 7, 1998

9/003833

Mitchell S. Felder - Hermitage PA

Infectech, Inc. - Sharon PA

C12M 124

4352879

A method of determining the presence or absence of a nonparaffinophilic microorganism in a specimen taken from a patient includes providing a receptacle containing an aqueous solution that does not contain a carbon source and inoculating the aqueous solution with the specimen. A slide having bound thereto a carbon source is placed into the receptacle. By analyzing the slide after exposure to the specimen, the presence or absence of a nonparaffinophilic microorganism in the specimen can be determined. An associated apparatus is also disclosed.

2006029, Dec 28, 2006

Jun 9, 2006

11/450075

Harry Diz - Erie PA, US
Mitchell Felder - Hermitage PA, US
Justin Felder - Hermitage PA, US

C10G 32/00

435281000

The present invention provides a method of hydrogen production from microorganisms, wherein a bioreactor provides an environment conducive to the production of hydrogen from hydrogen producing microorganisms and restrictive to the production of methane from methanogens. The method further includes an equalization tank that provides improved control of flow rates, particularly when combining the hydrogen production system with an industrial process such that organic feed material obtained from the industrial process is utilized in the hydrogen production system. The environment in the bioreactor is preferably maintained between about 3.5 and 6.0 pH.

2006028, Dec 21, 2006

Jun 9, 2006

11/450012

Harry Diz - Erie PA, US
Mitchell Felder - Hermitage PA, US
Justin Felder - Hermitage PA, US

C12M 1/00

435290100

The present invention provides a system of hydrogen production from microorganisms, wherein a bioreactor provides an environment conducive to the production of hydrogen from hydrogen producing microorganisms and restrictive to the production of methane from methanogens. The hydrogen production system further includes an equalization tank that provides improved control of flow rates, particularly when combining the hydrogen production system with an industrial facility such that organic feed material obtained from the industrial facility is utilizes in the hydrogen production system. The environment in the bioreactor is preferably maintained between about 3.5 and 6.0 pH.

2012000, Jan 5, 2012

Mar 16, 2010

13/254855

Mitchell S. Felder - Hermitage PA, US

MARV ENTERPRISES LLC - Hermitage PA

B01D 35/18, B01D 15/00, B01D 29/00, F17D 3/00, E03B 7/07

210175, 137 1, 137544, 210348, 2101981, 210194

An article and method to treat extracorporeally a patient's bodily fluid. The bodily fluid can include blood, cerebral spinal fluid and lymph. A first stage of the method includes applying a treatment. The treatment can comprise dosing with a medication, thermal treatment, or irradiation. The treatment can occur at levels that could otherwise compromise the patient's health. A second stage of the method substantially removes the treatment from the bodily fluid. The bodily fluid can then be returned to the patient. The article includes a treatment chamber that applies the treatment and a removal module for removing the treatment. The method can be a continuous process such as, for example, a dialysis process.

5707824, Jan 13, 1998

Nov 9, 1995

8/555734

Mitchell S. Felder - Hermitage PA
Robert A. Ollar - Milford PA

Infectech, Inc. - Sharon PA

C12Q 104, C12Q 124

435 34

A method of determining the presence of a paraffinophilic microorganism in a specimen taken from a patient is provided. The method includes providing a receptacle containing an aqueous solution and adjusting the solution to mimic the in vivo clinical conditions of the patient. The method then further includes inoculating the solution with the specimen and then placing in the receptacle a paraffin coated slide to bait the paraffinophilic microorganism. The slide is then analyzed after exposure to the specimen to determine the presence or absence of the paraffinophilic microorganism. An associated apparatus is also disclosed.

2006028, Dec 14, 2006

Jun 9, 2006

11/450560

Mitchell Felder - Hermitage PA, US
Harry Diz - Erie PA, US
Justin Felder - Hermitage PA, US

C12Q 1/04

435034000

The present invention provides a method identifying nonparaffinophilic microorganisms suitable for biodegradation or bioremediation that do not substantially produce methane. The method provides the growing of nonparaffinophilic microorganisms on substrates in a bioreactor, wherein the bioreactor provides an environment conducive to the metabolism of many nonparaffinophilic microorganisms while being restrictive to methanogens and methane production. The method may further include substrates coated with a gelatinous matrix, wherein the gelatinous matrix coating baits the nonparaffinophilic microorganisms.

2011029, Dec 1, 2011

Jun 10, 2011

13/157635

Mitchell S. Felder - Hermitage PA, US
Jay Rosen - Englewood Cliffs NJ, US

MARV ENTERPRISES LLC - Hermitage PA

A61M 1/36, A61M 1/14, A61M 1/34

604 501, 422 44, 2101951, 2101952

An article and method to treat extracorporeally a patient's bodily fluid. The bodily fluid can include blood, cerebral spinal fluid and lymph. A first stage of the method includes applying a treatment. The treatment can comprise dosing with a medication, thermal treatment, or irradiation. The treatment can occur at levels that could otherwise compromise the patient's health. A second stage of the method substantially removes the treatment from the bodily fluid. The bodily fluid can then be returned to the patient. The article includes a treatment chamber that applies the treatment and a removal module for removing the treatment. The method can be a continuous process such as, for example, a dialysis process.

2006027, Dec 7, 2006

May 31, 2006

11/444027

Mitchell Felder - Hermitage PA, US
Justin Felder - Hermitage PA, US
Harry Diz - Erie PA, US

C12M 3/00

435289100

The present invention provides a hydrogen production apparatus, where a bioreactor is combined with an industrial facility such that the industrial facility heats an organic feed material prior to conveyance of the organic feed material into the bioreactor. The apparatus includes a bioreactor, a feed container, a heating means such as a heat exchanger and an industrial facility with a heat waste source.